Motor neuron derivation from human embryonic and induced pluripotent stem cells: Experimental approaches and clinical perspectives

Stem Cell Research and Therapy

Volumn 5, Issue 4, 2014, Pages

  Faravelli, Irene ^a   Bucchia, Monica ^a   Rinchetti, Paola ^a   Nizzardo, Monica ^a   Simone, Chiara ^a   Frattini, Emanuele ^a   Corti, Stefania ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL INTERACTION; DISEASE MODEL; EMBRYONIC STEM CELL; FIBROBLAST; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOTONEURON; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; SPINAL MUSCULAR ATROPHY; STEM CELL TRANSPLANTATION; CELL CULTURE TECHNIQUE; CYTOLOGY; INDUCED PLURIPOTENT STEM CELL; METABOLISM;

BIOMARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MOTOR NEURONS;

EID: 84904337052     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt476     Document Type: Review

References (60)

1. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. M Mitne-Neto, M Machado-Costa, MC Marchetto, MH Bengtson, CA Joazeiro, H Tsuda, HJ Bellen, HC Silva, AS Oliveira, M Lazar, AR Muotri, M Zatz, Hum Mol Genet 2011 20 3642 3652 10.1093/hmg/ddr284 21685205
2. Diagnosis and management of motor neurone disease. CJ McDermott, PJ Shaw, BMJ 2008 336 658 662 10.1136/bmj.39493.511759.BE 18356234
3. GPs have key role in managing motor neurone disease. RW Orrell, Practitioner 2011 255 19 22 22235550
4. Spinal muscular atrophy. A D'Amico, E Mercuri, FD Tiziano, E Bertini, Orphanet J Rare Dis 2011 6 71 10.1186/1750-1172-6-71 22047105
5. Identification and characterization of a spinal muscular atrophy-determining gene. S Lefebvre, L Burglen, S Reboullet, O Clermont, P Burlet, L Viollet, B Benichou, C Cruaud, P Millasseau, M Zeviani, D Le Paslier, J Frézal, D Cohen, J Weissenbach, A Munnich, J Melki, Cell 1995 80 155 165 10.1016/0092-8674(95)90460-3 7813012
6. Dysregulation of axonal transport and motorneuron diseases. D Sau, P Rusmini, V Crippa, E Onesto, E Bolzoni, A Ratti, A Poletti, Biol Cell 2011 103 87 107 10.1042/BC20100093 21250942
7. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. PH Gordon, Aging Dis 2013 4 295 310 10.14336/AD.2013.0400295 24124634
8. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. M DeJesus-Hernandez, IR Mackenzie, BF Boeve, AL Boxer, M Baker, NJ Rutherford, AM Nicholson, NA Finch, H Flynn, J Adamson, N Kouri, A Wojtas, P Sengdy, GY Hsiung, A Karydas, WW Seeley, KA Josephs, G Coppola, DH Geschwind, ZK Wszolek, H Feldman, DS Knopman, RC Petersen, BL Miller, DW Dickson, KB Boylan, NR Graff-Radford, R Rademakers, Neuron 2011 72 245 256 10.1016/j.neuron.2011.09.011 21944778
9. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. S Lattante, GA Rouleau, E Kabashi, Hum Mutat 2013 34 812 826 10.1002/humu.22319 23559573
10. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. MS Rotunno, DA Bosco, Front Cell Neurosci 2013 7 253 24379756
11. Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS). AS Limpert, ME Mattmann, ND Cosford, Beilstein J Org Chem 2013 9 717 732 23766784
12. Stem cell technology for the study and treatment of motor neuron diseases. JS Lunn, SA Sakowski, T Federici, JD Glass, NM Boulis, EL Feldman, Regen Med 2011 6 201 213 10.2217/rme.11.6 21391854
13. Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. T Amemori, N Romanyuk, P Jendelova, V Herynek, K Turnovcova, P Prochazka, M Kapcalova, G Cocks, J Price, E Sykova, Stem Cell Res Ther 2013 4 68 10.1186/scrt219 23759119
14. Opinion: neural stem cell therapy for neurological diseases: dreams and reality. F Rossi, E Cattaneo, Nat Rev Neurosci 2002 3 401 409 10.1038/nrn809 11988779
15. Stem cell transplantation for neurodegenerative diseases. AE Rosser, R Zietlow, SB Dunnett, Curr Opin Neurol 2007 20 688 692 10.1097/WCO. 0b013e3282f132fc 17992090
16. GDNF delivery using human neural progenitor cells in a rat model of ALS. SM Klein, S Behrstock, J McHugh, K Hoffmann, K Wallace, M Suzuki, P Aebischer, CN Svendsen, Hum Gene Ther 2005 16 509 521 10.1089/hum.2005.16.509 15871682
17. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. M Suzuki, J McHugh, C Tork, B Shelley, SM Klein, P Aebischer, CN Svendsen, PLoS One 2007 2 689 10.1371/journal.pone.0000689 17668067
18. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. S Behrstock, A Ebert, J McHugh, S Vosberg, J Moore, B Schneider, E Capowski, D Hei, J Kordower, P Aebischer, CN Svendsen, Gene Ther 2006 13 379 388 10.1038/sj.gt.3302679 16355116
19. Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. CV Alvarez, M Garcia-Lavandeira, ME Garcia-Rendueles, E Diaz-Rodriguez, AR Garcia-Rendueles, S Perez-Romero, TV Vila, JS Rodrigues, PV Lear, SB Bravo, J Mol Endocrinol 2012 49 89 R111 10.1530/JME-12-0072 22822049
20. Clinical translation of human neural stem cells. A Tsukamoto, N Uchida, A Capela, T Gorba, S Huhn, Stem Cell Res Ther 2013 4 102 10.1186/scrt313 23987648
21. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. J Jang, JE Yoo, JA Lee, DR Lee, JY Kim, YJ Huh, DS Kim, CY Park, DY Hwang, HS Kim, HC Kang, DW Kim, Exp Mol Med 2012 44 202 213 10.3858/emm.2012.44.3.015 22179105
22. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. K Takahashi, S Yamanaka, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174
23. From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. S Karumbayaram, P Lee, SF Azghadi, AR Cooper, M Patterson, DB Kohn, A Pyle, A Clark, J Byrne, JA Zack, K Plath, WE Lowry, Stem Cells Transl Med 2012 1 36 43 10.5966/sctm.2011-0001 23197638
24. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. JT Dimos, KT Rodolfa, KK Niakan, LM Weisenthal, H Mitsumoto, W Chung, GF Croft, G Saphier, R Leibel, R Goland, H Wichterle, CE Henderson, K Eggan, Science 2008 321 1218 1221 10.1126/science.1158799 18669821
25. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. S Corti, M Nizzardo, C Simone, M Falcone, M Nardini, D Ronchi, C Donadoni, S Salani, G Riboldi, F Magri, G Menozzi, C Bonaglia, F Rizzo, N Bresolin, GP Comi, Sci Transl Med 2012 4 165ra162 23253609
26. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. TM Jessell, Nat Rev Genet 2000 1 20 29 10.1038/35049541 11262869
27. Directed differentiation of embryonic stem cells into motor neurons. H Wichterle, I Lieberam, JA Porter, TM Jessell, Cell 2002 110 385 397 10.1016/S0092-8674(02)00835-8 12176325
28. Bone morphogenetic proteins: a critical review. B Bragdon, O Moseychuk, S Saldanha, D King, J Julian, A Nohe, Cell Signal 2011 23 609 620 10.1016/j.cellsig.2010.10.003 20959140
29. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. P Reinhardt, M Glatza, K Hemmer, Y Tsytsyura, CS Thiel, S Höing, S Moritz, JA Parga, L Wagner, JM Bruder, G Wu, B Schmid, A Röpke, J Klingauf, JC Schwamborn, T Gasser, HR Schöler, J Sterneckert, PLoS One 2013 8 59252 10.1371/journal.pone.0059252 23533608
30. Convergent inductive signals specify midbrain, hindbrain, and spinal cord identity in gastrula stage chick embryos. J Muhr, E Graziano, S Wilson, TM Jessell, T Edlund, Neuron 1999 23 689 702 10.1016/S0896-6273(01)80028-3 10482236
31. Early posterior neural tissue is induced by FGF in the chick embryo. KG Storey, A Goriely, CM Sargent, JM Brown, HD Burns, HM Abud, JK Heath, Development 1998 125 473 484 9425142
32. Assigning the positional identity of spinal motor neurons: rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids. JP Liu, E Laufer, TM Jessell, Neuron 2001 32 997 1012 10.1016/S0896-6273(01)00544-X 11754833
33. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Y Echelard, DJ Epstein, B St-Jacques, L Shen, J Mohler, JA McMahon, AP McMahon, Cell 1993 75 1417 1430 10.1016/0092-8674(93)90627-3 7916661
34. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. KF Liem Jr, G Tremml, H Roelink, TM Jessell, Cell 1995 82 969 979 10.1016/0092-8674(95)90276-7 7553857
35. Wnt won the war: antagonistic role of Wnt over Shh controls dorso-ventral patterning of the vertebrate neural tube. F Ulloa, E Marti, Dev Dyn 2010 239 69 76 19681160
36. Wnt signaling in axon guidance. Y Zou, Trends Neurosci 2004 27 528 532 10.1016/j.tins.2004.06.015 15331234
37. Maturation of spinal motor neurons derived from human embryonic stem cells. T Takazawa, GF Croft, MW Amoroso, L Studer, H Wichterle, AB Macdermott, PLoS One 2012 7 40154 10.1371/journal.pone.0040154 22802953
38. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. SM Chambers, CA Fasano, EP Papapetrou, M Tomishima, M Sadelain, L Studer, Nat Biotechnol 2009 27 275 280 10.1038/nbt.1529 19252484
39. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. MW Amoroso, GF Croft, DJ Williams, S O'Keeffe, MA Carrasco, AR Davis, L Roybon, DH Oakley, T Maniatis, CE Henderson, H Wichterle, J Neurosci 2013 33 574 586 10.1523/JNEUROSCI.0906-12.2013 23303937
40. A functionally characterized test set of human induced pluripotent stem cells. GL Boulting, E Kiskinis, GF Croft, MW Amoroso, DH Oakley, BJ Wainger, DJ Williams, DJ Kahler, M Yamaki, L Davidow, CT Rodolfa, JT Dimos, S Mikkilineni, AB MacDermott, CJ Woolf, CE Henderson, H Wichterle, K Eggan, Nat Biotechnol 2011 29 279 286 10.1038/nbt.1783 21293464
41. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. MF Burkhardt, FJ Martinez, S Wright, C Ramos, D Volfson, M Mason, J Garnes, V Dang, J Lievers, U Shoukat-Mumtaz, R Martinez, H Gai, R Blake, E Vaisberg, M Grskovic, C Johnson, S Irion, J Bright, B Cooper, L Nguyen, I Griswold-Prenner, A Javaherian, Mol Cell Neurosci 2013 56 355 364 23891805
42. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. ME Hester, MJ Murtha, S Song, M Rao, CJ Miranda, K Meyer, J Tian, G Boulting, DV Schaffer, MX Zhu, SL Pfaff, FH Gage, BK Kaspar, Mol Ther 2011 19 1905 1912 10.1038/mt.2011.135 21772256
43. Differentiation of spinal motor neurons from pluripotent human stem cells. BY Hu, SC Zhang, Nat Protoc 2009 4 1295 1304 10.1038/nprot.2009.127 19696748
44. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. S Karumbayaram, BG Novitch, M Patterson, JA Umbach, L Richter, A Lindgren, AE Conway, AT Clark, SA Goldman, K Plath, M Wiedau-Pazos, HI Kornblum, WE Lowry, Stem Cells 2009 27 806 811 10.1002/stem.31 19350680
45. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. D Sareen, JG O'Rourke, P Meera, AK Muhammad, S Grant, M Simpkinson, S Bell, S Carmona, L Ornelas, A Sahabian, T Gendron, L Petrucelli, M Baughn, J Ravits, MB Harms, F Rigo, CF Bennett, TS Otis, CN Svendsen, RH Baloh, Sci Transl Med 2013 5 208ra149 10.1126/scitranslmed.3007529 24154603
46. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. T Wada, M Honda, I Minami, N Tooi, Y Amagai, N Nakatsuji, K Aiba, PLoS One 2009 4 6722 10.1371/journal.pone. 0006722 19701462
47. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. H Zeng, M Guo, K Martins-Taylor, X Wang, Z Zhang, JW Park, S Zhan, MS Kronenberg, A Lichtler, HX Liu, FP Chen, L Yue, XJ Li, RH Xu, PLoS One 2010 5 11853 10.1371/journal. pone.0011853 20686615
48. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. SC Zhang, M Wernig, ID Duncan, O Brustle, JA Thomson, Nat Biotechnol 2001 19 1129 1133 10.1038/nbt1201-1129 11731781
49. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. H Lee, GA Shamy, Y Elkabetz, CM Schofield, NL Harrsion, G Panagiotakos, ND Socci, V Tabar, L Studer, Stem Cells 2007 25 1931 1939 10.1634/stemcells.2007-0097 17478583
50. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. S Erceg, S Lainez, M Ronaghi, P Stojkovic, MA Perez-Arago, V Moreno-Manzano, R Moreno-Palanques, R Planells-Cases, M Stojkovic, PLoS One 2008 3 2122 10.1371/journal.pone.0002122 18461168
51. The ROCK inhibitor Y-26732 enhances the survival and proliferation of human embryonic stem cell-derived neural progenitor cells upon dissociation. R Rungsiwiwut, C Manolertthewan, P Numchaisrika, V Ahnonkitpanit, P Virutamasen, M Techakumphu, K Pruksananonda, Cells Tissues Organs 2013 198 127 138 10.1159/000354031 24158103
52. Progesterone and 17beta-estradiol increase differentiation of mouse embryonic stem cells to motor neurons. R López-González, I Camacho-Arroyo, I Velasco, IUBMB Life 2011 63 930 939 10.1002/iub.560 21901819
53. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. H Xue, S Wu, ST Papadeas, S Spusta, AM Swistowska, CC MacArthur, MP Mattson, NJ Maragakis, MR Capecchi, MS Rao, X Zeng, Y Liu, Stem Cells 2009 27 1836 1846 10.1002/stem.129 19544414
54. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. GC Parker, X Li, RA Anguelov, G Toth, A Cristescu, G Acsadi, Neurotox Res 2008 13 39 48 10.1007/BF03033366 18367439
55. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. MC Marchetto, AR Muotri, Y Mu, AM Smith, GG Cezar, FH Gage, Cell Stem Cell 2008 3 649 657 10.1016/j.stem.2008.10. 001 19041781
56. Constructing and deconstructing stem cell models of neurological disease. SS Han, LA Williams, KC Eggan, Neuron 2011 70 626 644 10.1016/j.neuron.2011.05. 003 21609821
57. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. YW Jung, E Hysolli, KY Kim, Y Tanaka, IH Park, Curr Opin Neurol 2012 25 125 130 10.1097/WCO.0b013e3283518226 22357218
58. Parkinson's disease in a dish-using stem cells as a molecular tool. JL Badger, O Cordero-Llana, EM Hartfield, R Wade-Martins, Neuropharmacology 2014 76 88 96 24035919
59. Induced neural stem cells (iNSCs) in neurodegenerative diseases. A Hermann, A Storch, J Neural Transm 2013 120 19 S25 10.1007/s00702-013-1042-9 23720190
60. High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1. Q Qu, D Li, KR Louis, X Li, H Yang, Q Sun, SR Crandall, S Tsang, J Zhou, CL Cox, J Cheng, F Wang, Nat Commun 2014 5 3449 24622388